RESEARCH COMMUNICATIONS OF THE 28th ECVIM-CA CONGRESS

At the end of treatment, 95 patients were alive, while 33 died. In patients with elevated blood urea nitrogen (BUN) levels at the first visit, the risk for death was high (P = 0.001, odds ratio [OR]: 4.53; sensitivity, 87%; specificity, 40%). In patients with Spec‐cPL > 700 μg/L at the first visit, the risk for death tended to be high (P = 0.06, OR: 3.03). However, there were no significant differences in clinical symptoms, other blood test markers, and abdominal ultrasonography findings at the first visit. Furthermore,he risk for death was very high in patients in whom elevated BUN levels were noted after 3‐5 days of treatment (P < 0.0001, OR: 75; sensitivity, 88%; specificity, 91%). In addition, the risk for death was high in patients with thrombocytopenia (platelet count < 148×103/μL) during treatment (P = 0.002, OR: 10; sensitivity, 91%; specificity, 50%).